How much funding has CorWave raised?

CorWave has raised $84.2M in total funding, most recently a Series C round.

Who are CorWave's investors?

CorWave's investors include Sofinnova Partners, Société de Projets Industriels (SPI) Fund, European Innovation Council Fund, Novo Holdings A/S, Bpifrance, Ysios Capital.

Where is CorWave headquartered?

CorWave is headquartered in Clichy, France.

What industry is CorWave in?

CorWave operates in Healthcare.

CorWave

Unique Blood Pumps Inspired By Nature - CorWave EN

Clichy, France · Founded 2012 · $84.2M raised

Healthcare

Headquarters: Clichy
Employees: 51–200
Founded: 2012
Business Model: B2B

Website: corwave.com
Total Funding: $84.2M
Last Round: $28.6M Series CJun 2023
Rounds: 3

About

CorWave is a French clinical-stage medical device company headquartered in Clichy, near Paris, developing next-generation implantable heart-assist pumps based on a proprietary undulating wave membrane technology. Unlike conventional continuous-flow LVADs (left ventricular assist devices), CorWave's pump mimics physiological pulsatile blood flow, with the goal of reducing complications such as thrombosis and improving quality of life for advanced heart failure patients. Founded in 2012 by startup studio MD Start, CorWave completed the world's first human implant of its LVAS device in 2025 at St Vincent's Health Australia and is advancing toward pivotal clinical trials. The company has raised over 80 million euros in equity from investors including Bpifrance, Sofinnova Partners, Novo Holdings, Exor Ventures, and the EIC Fund, and employs more than 90 people.

Summary

CorWave is a Healthcare company based in Clichy, France, founded in 2012. It has raised $84.2M in total across 3 rounds, most recently a $28.6M Series C round in Jun 2023. Investors include Sofinnova Partners, Société de Projets Industriels (SPI) Fund and European Innovation Council Fund.

LinkedIn X (Twitter)